Dow Down 0.08% Nasdaq Down 0.35%

More On ACCP

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

(ACCP)

-Other OTC
0.00 0.00(0.00%) N/A
|Pre-Market : NaN
Prev Close:N/A
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:7.00
Beta:0.89
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.18 - 0.60
Volume:0
Avg Vol (3m):N/A
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-34.16
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in .

Headlines

  • No Headlines available for ACCP at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Access Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in the development of novel therapeutics for the treatment of cancer and supportive care of cancer patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback